article thumbnail

Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe

Digital Health Global

About Massive Bio: Massive Bio’s vision is to cover entire Pharma value chain with disruptive solutions to improve entire ecosystem from drug development to commercialization. Oncology Network community practices. More information at www.mika.health. 1 Robert NJ, et al. ASCO 2021 Meeting Abstract.